Who is Mala Gaonkar and what is SurgoCap?

Mala Gaonkar is a veteran investor who founded SurgoCap Partners, a women-led hedge fund focused on data-driven, cross-sector equity strategies. The firm reportedly reached $6 billion in assets within three years. For Indian investors, the appeal is process discipline, diversification beyond domestic equities, and access to global stock-picking with strong risk controls.

Why did SurgoCap’s AUM rise so fast?

Reports indicate SurgoCap Partners AUM growth came mainly from net inflows, not outsized gains, during a tough fundraising cycle. Allocators likely value its data science investing approach, risk management, and cross-sector breadth. This combination can fit portfolios seeking smoother returns. Still, investors should verify capacity, liquidity, and performance consistency before allocating.

How can Indian family offices invest in such funds?

Typical routes include Category III AIF feeder funds, GIFT City IFSC structures, offshore feeders via registered distributors, or FPI setups for larger allocators. Individuals may use the RBI’s LRS up to USD 250,000 annually. Confirm eligibility, minimums, KYC, and reporting. Ask if the Mala Gaonkar hedge fund is currently open and which share classes are available.

What risks should investors consider before allocating?

Key risks include model decay, factor crowding, liquidity constraints, and USD-INR currency exposure. Review drawdowns, gross and net exposure ranges, and portfolio turnover. Check audit quality, valuation policies, and side pocket rules. Ensure fit with existing holdings and tax framework, especially for AIF Category III or offshore structures accessible from India.

Global Market Insights

January 26: Mala Gaonkar’s SurgoCap Hits $6B as Allocators Chase Data

ByDanny Kontos January 26, 2026January 26, 2026

Mala Gaonkar hedge fund SurgoCap Partners has reached $6 billion in assets in three years, roughly ₹50,000 crore at current rates. The rise, in a tough fundraising cycle, shows allocator demand for data-driven, cross-sector equity strategies. For Indian family offices and AIFs, access, capacity, and timing matter. With SurgoCap Partners AUM growing mainly from inflows, not performance, diligence should focus on risk, liquidity, and fees. We break down what this means for India-based allocators seeking diversification beyond domestic equities.